Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
Enveric continues focused investment advancing novel neuroplastogenic molecules for the treatment of mental health disorders CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to…
Details